Status Active Effective start/end date 1/05/25 → 30/04/26
Epidermal Growth Factor Receptor
Pharmacology, Toxicology and Pharmaceutical Science
100%
Lysosome
Medicine and Dentistry
15%
Protein Tyrosine Kinase Inhibitor
Pharmacology, Toxicology and Pharmaceutical Science
11%
Cancer Growth
Pharmacology, Toxicology and Pharmaceutical Science
11%
Monoclonal Antibody
Pharmacology, Toxicology and Pharmaceutical Science
11%
Malignant Neoplasm
Pharmacology, Toxicology and Pharmaceutical Science
11%
Epidermal Growth Factor Receptor Kinase Inhibitor
Pharmacology, Toxicology and Pharmaceutical Science
11%
Clathrin
Pharmacology, Toxicology and Pharmaceutical Science
11%